Search Results - "Saini, Rajneet Kaur"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Unveiling the inhibitory mechanism of peptidomimetic inhibitor against Aβ42 aggregation and protofibril disaggregation by molecular dynamics by Kaur, Rajdeep, Kaur Saini, Rajneet, Singh, Pritpal, Goyal, Bhupesh

    Published in Journal of molecular liquids (01-08-2021)
    “…The peptidomimetic compound C1 stabilized the non-aggregation-prone helical conformation of the Aβ42 monomer. C1 destabilized the S-shaped Aβ42 protofibril…”
    Get full text
    Journal Article
  2. 2

    Impact of Mutations on the Conformational Transition from α‑Helix to β‑Sheet Structures in Arctic-Type Aβ40: Insights from Molecular Dynamics Simulations by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Deepti, Goyal, Bhupesh

    Published in ACS omega (15-09-2020)
    “…The amyloid-β (Aβ) protein aggregation into toxic oligomers and fibrils has been recognized as a key player in the pathogenesis of Alzheimer’s disease. Recent…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Targeting Human Islet Amyloid Polypeptide Aggregation and Toxicity in Type 2 Diabetes: An Overview of Peptide-Based Inhibitors by Saini, Rajneet Kaur, Goyal, Deepti, Goyal, Bhupesh

    Published in Chemical research in toxicology (16-11-2020)
    “…Type 2 diabetes (T2D) is a chronic metabolic disease characterized by insulin resistance and a progressive loss of pancreatic islet β-cell mass, which leads to…”
    Get full text
    Journal Article
  5. 5

    Molecular insights into Aβ42 protofibril destabilization with a fluorinated compound D744: A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Bhupesh

    Published in Journal of molecular recognition (01-12-2017)
    “…The aggregation of amyloid β‐peptide (Aβ42) into toxic oligomers, fibrils, has been identified as a key process in Alzheimer's disease (AD) progression. The…”
    Get full text
    Journal Article
  6. 6

    Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ42 aggregation and protofibril destabilization: A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Deepti, Goyal, Bhupesh

    “…Amyloid-β (Aβ) peptide instinctively aggregate and form plaques in the brain of Alzheimer's disease (AD) patients. At present, there is no cure or treatment…”
    Get full text
    Journal Article
  7. 7

    Effect of Piedmont mutation (L34V) on the structure, dynamics, and aggregation of Alzheimer’s Aβ40 peptide by Saini, Rajneet Kaur, Thakur, Hema, Goyal, Bhupesh

    Published in Journal of molecular graphics & modelling (01-06-2020)
    “…The amyloid-β (Aβ) aggregation in the brain has been associated with the development of Alzheimer’s disease (AD). The previous studies have reported that…”
    Get full text
    Journal Article
  8. 8

    Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β42 peptide in Alzheimer's disease: key insights from molecular dynamics simulations by Shuaib, Suniba, Saini, Rajneet Kaur, Goyal, Deepti, Goyal, Bhupesh

    “…The aggregation of amyloid-β 42 (Aβ 42 ) peptide into toxic oligomers and fibrils is a key step in the Alzheimer disease pathogenesis. The recent studies…”
    Get full text
    Journal Article
  9. 9

    Molecular insights into the effect L17A/F19A double mutation on the structure and dynamics of Aβ40: A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Deepti, Goyal, Bhupesh

    Published in Journal of cellular biochemistry (01-11-2018)
    “…The aggregation of amyloid‐β (Aβ) peptide has been associated with the pathogenesis of Alzheimer disease. The recent studies highlighted that L17A/F19A double…”
    Get full text
    Journal Article
  10. 10

    Molecular insights into the effect L17A/F19A double mutation on the structure and dynamics of Aβ 40 : A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Deepti, Goyal, Bhupesh

    Published in Journal of cellular biochemistry (01-11-2018)
    “…The aggregation of amyloid-β (Aβ) peptide has been associated with the pathogenesis of Alzheimer disease. The recent studies highlighted that L17A/F19A double…”
    Get full text
    Journal Article
  11. 11

    Molecular insights into Aβ 42 protofibril destabilization with a fluorinated compound D744: A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Bhupesh

    Published in Journal of molecular recognition (01-12-2017)
    “…The aggregation of amyloid β-peptide (Aβ ) into toxic oligomers, fibrils, has been identified as a key process in Alzheimer's disease (AD) progression. The…”
    Get full text
    Journal Article
  12. 12

    Molecular insights into A[beta]42 protofibril destabilization with a fluorinated compound D744: A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Bhupesh

    Published in Journal of molecular recognition (01-12-2017)
    “…The aggregation of amyloid [beta]-peptide (A[beta]42) into toxic oligomers, fibrils, has been identified as a key process in Alzheimer's disease (AD)…”
    Get full text
    Journal Article
  13. 13

    Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β 42 peptide in Alzheimer's disease: key insights from molecular dynamics simulations by Shuaib, Suniba, Saini, Rajneet Kaur, Goyal, Deepti, Goyal, Bhupesh

    “…The aggregation of amyloid-β (Aβ ) peptide into toxic oligomers and fibrils is a key step in the Alzheimer disease pathogenesis. The recent studies highlighted…”
    Get full text
    Journal Article
  14. 14

    Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ 42 aggregation and protofibril destabilization: A molecular dynamics simulation study by Saini, Rajneet Kaur, Shuaib, Suniba, Goyal, Deepti, Goyal, Bhupesh

    “…Amyloid-β (Aβ) peptide instinctively aggregate and form plaques in the brain of Alzheimer's disease (AD) patients. At present, there is no cure or treatment…”
    Get full text
    Journal Article
  15. 15

    Effect of Piedmont mutation (L34V) on the structure, dynamics, and aggregation of Alzheimer's Aβ 40 peptide by Saini, Rajneet Kaur, Thakur, Hema, Goyal, Bhupesh

    Published in Journal of molecular graphics & modelling (01-06-2020)
    “…The amyloid-β (Aβ) aggregation in the brain has been associated with the development of Alzheimer's disease (AD). The previous studies have reported that…”
    Get full text
    Journal Article
  16. 16

    Insights into the Inhibitory Mechanism of Dicyanovinyl‐Substituted J147 Derivative against Aβ42 Aggregation and Protofibril Destabilization: A Molecular Dynamics Simulation Study by Shuaib, Suniba, Saini, Rajneet Kaur, Goyal, Deepti, Goyal, Bhupesh

    Published in ChemistrySelect (Weinheim) (01-02-2017)
    “…The self‐assembly of amyloid β‐peptide (Aβ) into β‐sheet enriched fibrillar aggregates is associated with Alzheimer's disease (AD). A disease modifying therapy…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Insights into the Inhibitory Mechanism of Dicyanovinyl‐Substituted J147 Derivative against Aβ 42 Aggregation and Protofibril Destabilization: A Molecular Dynamics Simulation Study by Shuaib, Suniba, Saini, Rajneet Kaur, Goyal, Deepti, Goyal, Bhupesh

    Published in ChemistrySelect (Weinheim) (01-02-2017)
    “…The self‐assembly of amyloid β‐peptide (Aβ) into β‐sheet enriched fibrillar aggregates is associated with Alzheimer's disease (AD). A disease modifying therapy…”
    Get full text
    Journal Article